Doctor profile · Federal record
Dr. Philip McAndrew, M.D.
Gastroenterology Physician (CMS: Gastroenterology) · Providence, RI
- NPI 1376614966
- Accepts Medicare
- 31 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
148 W River St, Suite 3
Providence, RI 029042615
(401) 421-6306
fax (401) 453-0330
Credentials & registration
- NPI registered
- November 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RG0100X — NUCC code
- State license (1)
- Rhode Island #10870
- Medicaid
- RI #7009568
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1376614966. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
35,810
Distinct HCPCS
10
Medicare allowed
$408,310
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1439 |
Injection, ferric carboxymaltose, 1 mg | 21,750 | 23 | $1 | |
J3380 |
Injection, vedolizumab, 1 mg | 11,400 | 16 | $22 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 1,790 | 16 | $33 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 140 | 17 | $0 | |
45380 |
Biopsy of large bowel using a flexible endoscope | 124 | 124 | $137 | |
43239 |
Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 99 | 96 | $67 | |
96365 |
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 71 | 42 | $66 | |
G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 68 | 68 | $5 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 63 | 55 | $91 | |
45385 |
Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | 59 | $250 |
In context: peer comparison
Among 17 peers in Providence Gastroenterology Physician, average services per provider: 378. This provider delivers 95× the peer median.Open Payments
Industry payments received
All-time total
$2,413
Transactions
21
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | 14 | $2,035.52 | |
| Abbvie INC. | 4 | $152.76 | |
| Gilead Sciences, INC. | 1 | $107.57 | |
| Boston Scientific Corporation | 1 | $101.06 | |
| Pfizer INC. | 1 | $15.87 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
719
Patients
207
Total drug cost
$45,638
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Omeprazole | Generic | 370 | 117 | $4,866 |
| Famotidine | Generic | 96 | 42 | $2,410 |
| Pantoprazole Sodium | Generic | 64 | 19 | $1,065 |
| Dicyclomine Hcl | Generic | 40 | 0 | $1,705 |
| Esomeprazole Magnesium | Generic | 34 | 0 | $4,665 |
| Sutab (Sod Sulf/Pot Chloride/Mag Sulf) | Brand | 29 | 29 | $4,491 |
| Linzess (Linaclotide) | Brand | 25 | 0 | $17,450 |
| Balsalazide Disodium | Generic | 21 | 0 | $7,074 |
| Ursodiol | Generic | 15 | 0 | $1,533 |
| Ondansetron Hcl | Generic | 13 | 0 | $241 |
Hospital affiliations
Frequently asked questions
What is Dr. Philip McAndrew's medical specialty?
Dr. Philip McAndrew practices Gastroenterology Physician in Providence, RI.
Where does Dr. Philip McAndrew practice?
Dr. Philip McAndrew practices at 148 W River St, Providence, RI 029042615. Office phone: 4014216306.
What is Dr. Philip McAndrew's NPI?
Dr. Philip McAndrew's National Provider Identifier (NPI) is 1376614966, issued by NPPES.
Does Dr. Philip McAndrew accept Medicare assignment?
Yes. Dr. Philip McAndrew accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip McAndrew commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, vedolizumab, 1 mg (HCPCS J3380); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.